LogiPharma 2018 US

September 05 - 06, 2018

Hilton Penn’s Landing, Philadelphia, PA

Contact: 1.888.482.6012

DAY TWO: Becoming More Agile to Maintain Service Levels and Meet the Needs of a Changing Customer

7:15 am - 8:15 am Continental Breakfast & Registration

img

Marissa Alvord

Executive Director
LogiPharma USA

8:20 am - 8:35 am Chairperson’s Welcome and Opening Remarks

Frederic Laluyaux - President & CEO Aera Technology
img

Frederic Laluyaux

President & CEO
Aera Technology

8:35 am - 8:55 am Keynote | Driving Supply Chain Transformation to Increase Profitability

Daniel Hoey - Senior Vice President, Global Supply Chain Teva Pharmaceuticals
After a series major acquisitions, the world’s largest generic manufacturer is embarking on a complete company turn around on a massive scale. Daniel Hoey, Senior Vice President, Global Supply Chain at Teva Pharmaceuticals is transforming the entire supply chain to reduce costs to stabilize the company and deliver higher profitability. This massive undertaking involves changing the portfolio, consolidating distribution globally, improving cash flow and it’s coinciding with a new ERP implementation on a global scale. Gain insights and lessons learned including:
•Personnel and leadership change to support the new framework
•Reducing the manufacturing network and consolidating the distribution footprint
•Inventory reduction plans to improve cash flow

img

Daniel Hoey

Senior Vice President, Global Supply Chain
Teva Pharmaceuticals

8:55 am - 9:25 am Fireside Chat | Opening the Curtains, Pharma From the Perspective of the Care Provider

Steve Kiewiet - Vice President, Supply Chain BJC HealthCare
In healthcare, providers get very little access to manufacturers, and in most cases, manufacturers are pretty far removed from patient care under the current wholesaler model. There is an opportunity to improve that as models and strategies are on the edge of disruption. Additionally, federal regulations are increasingly treating hospital pharmacies like manufacturers and providers are now most at risk in these transactions, leading to the rise in IDNs starting their own manufacturing programs, specialty pharmacies and self-distribution models. What do pressures look like internally for hospital systems? How will supply chains need to adapt to better support providers and patients? Heads of Supply Chain from transformative IDNs will weigh in on current market pressures and disruptions, including:
•Serialization and mandates for buyers of products
•Evaluating and operationalizing 503B programs
•Self distribution models to drive efficiencies, mitigate risk and achieve savings

img

Steve Kiewiet

Vice President, Supply Chain
BJC HealthCare

Many feel that the next 5-10 years will be transformational for what we’ll all come to expect for healthcare delivery. From customer expectations around free and fast delivery, rising costs of healthcare and an aging population, the complexities of personalized medicines and more, healthcare distribution and delivery are on course to be completely disrupted. In this Town Hall, healthcare providers and manufacturers will share their thoughts on the biggest factors that will impact healthcare delivery and distribution in the future. Join the conversation and pose questions to the speakers and offer your own thoughts on changes that can be made now to better support distribution and delivery in the future.

Manufacturer Perspectives:
Paul Testa, Group Vice President, Shire
Kevin Cook, Vice President, Supply Chain North America, Sandoz

Healthcare Provider Perspectives:
Steve Kiewiet, Vice President, Supply Chain, BJC HealthCare 

img

Paul Testa

Group Vice President
Shire

img

Kevin Cook

VP Supply Chain North America
Sandoz

img

Steve Kiewiet

Vice President, Supply Chain
BJC HealthCare

10:10 am - 10:50 am Recharge Morning Break

Grab a cup of caffeine in our LogiLounge and enjoy delightful treats! Don’t forget to network your way through our exhibit hall and learn more about our great exhibitors.

10:50 am - 11:25 am Panel Discussion and Live Polling | Expanding the Supply Chain, Developing a Global Distribution Strategy to Capitalize on New Market Opportunities

Angela Bagley - Global Head of Planning, Logistics and Master Data Celgene Kawa Chiu - Senior Director, Global Supply Chain Genentech A. Bahadır Büyükkaymaz - Special Cargo Manager Turkish Cargo
Most pharma companies focus on a few countries and when it comes time to go global, so much is underestimated. Novel therapies and biologics add great complexity to distribution and every country has their own level of complexity. How is the game being played in different regions and countries and how can you build capabilities for that? How do you build a global supply chain when it’s a capability you’re lacking? What is the best way to get acquainted with a particular region or country?
Hear lessons learned when going global, including:
•Selecting the right places to go and the best network approach
•Mitigating the cost of complexity around investment in resources
•Late stage customization strategies including packaging and labelling

img

Angela Bagley

Global Head of Planning, Logistics and Master Data
Celgene

img

Kawa Chiu

Senior Director, Global Supply Chain
Genentech

img

A. Bahadır Büyükkaymaz

Special Cargo Manager
Turkish Cargo

11:25 am - 11:35 am How On-Demand, Digital Services Are Transforming Performance and Automating the Entire Cold Chain

Gisli Herjolfsson - CEO Controlant
img

Gisli Herjolfsson

CEO
Controlant

11:35 am - 11:55 am Supply Chain Fluidity Protocols, Moving Through the Ports More Quickly

Sam Ruda - Deputy Director The Port Authority of NY & NJ
As pharma pipeline growth continues in the areas of biologics and novel therapies which require stringent temperature controls, there is increasing concern around ensuring all t’s are crossed and i’s are dotted when it comes to clearing shipments through ports. The Port Authority of New York and New Jersey is the third busiest container port in the US and Deputy Director, Sam Ruda has seen it all when it comes to air and ocean transportation. Sam will shed light on how the Port Authority of New York and New Jersey works in partnership with other agencies, including the Department of Homeland Security, licensed customs brokers and other partners to ensure the safety and efficiency of shipments. Sam will also shed light on:
•         Protocols for supply chain fluidity
•         CBP/US Customs clearance
•         Marine terminal processes
•         The role of the Army Corps of Engineers
•         Key performance processes and best practices

img

Sam Ruda

Deputy Director
The Port Authority of NY & NJ

11:55 am - 12:15 pm Alleviating Delays At the Border and Mitigating Risk, A CTPAT/ISA Journey

Noam Atar - Senior Director, Finance & Supply Chain Ferring Pharmaceuticals
Customs delays at the US border are an increasingly common frustration for supply chain leaders. Delays are even more stressful when you consider the unique needs of products that require specific controls. The CTPAT/ISA program allows companies to self-audit to make the customs process happen more quickly, lessening risks and ensuring security. Noam Atar, Senior Director, Supply Chain and Finance at Ferring Pharmaceuticals has a unique vision on the supply chain, coming into the role from a finance background. While working in the finance division of Ferring in Israel, he implemented a similar program to make shipments faster and with less risk. Hear lessons learned around how to start the CTPAT/ISA programs, including:
•         Aligning with security rules to ensure compliance
•         Administering and passing a self-audit
•         Improving overall supply chain risk mitigation

img

Noam Atar

Senior Director, Finance & Supply Chain
Ferring Pharmaceuticals

12:15 pm - 12:25 pm Customs and Border Clearance Q&A

12:25 pm - 1:25 pm Lunch For All Attendees

Agility is one of the biggest pain points when it comes to working with external manufacturers and many experience demand surges frequently. Problems often start with a bad forecast and get further complicated by changes beyond manufacturer control like new technologies bringing in more effective drugs in a category, changing supply levels, etc. How can you build more agility into manufacturing and supply chain to better respond to changes? How can you revise network planning strategy to become more agile? What new technologies and applications support agility?
Find out how to:
•Examine API sources to reduce risk
•Modify network planning strategy to be more flexible
•Re-evaluate inventory strategy and customer segmentation

img

Marcelo Coutu

Americas Head, Global Logistics Services
Bristol Myers Squibb

img

Ron Bohl

Senior Director, Supply Chain Operations
Elanco Animal Health

img

Stephen Macrides

Senior Vice President, Global Supply Chain
Endo Ventures Limited

img

Michele Dorris

Executive Director, Supply Chain
Sandoz

img

Neil Ackerman

Senior Director, Enterprise Supply Chain Global Planning and Innovation
Johnson and Johnson

General Session

2:00 pm - 2:20 pm Case Study | Contingency Planning to Maintain Business Continuity, Lessons Learned One Year On
Tiffany Cavallaro - Director, Supply Chain Amgen
The hurricane season of 2017 brought tremendous wide-scale devastation and significant disruptions to pharma supply chains. Puerto Rico, with its 50 pharmaceutical manufacturing plants experienced the worst destruction and set the spotlight on contingency planning, disaster recovery and resiliency.  How can stock be positioned differently going into hurricane season to be more prepared? What does a robust plan look like to mitigate supply chain disruption? In the weeks after Hurricane Maria, Tiffany Cavallaro, Director, US Regional Supply Chain for Amgen realized just how important. Amgen’s continuity planning was to ensuring supply through this difficult time.  Tiffany will share key lessons learned to mitigate disruption, including:
•         Maintaining executable business plans in the ever changing world of technology
•         Regulatory hurdles unraveled
•         Inventory Safety Stock Considerations
•         Partnering with the surrounding community

img

Tiffany Cavallaro

Director, Supply Chain
Amgen

General Session

2:20 pm - 2:35 pm Case Study Call to Action | How Can the Industry Come Together to Support Each Other and Make Events like Hurricane Maria Less Impactful?

Creative Boardroom

1:25 pm - 2:35 pm Virtual Pharma Focus | Best Practices for Managing an Outsourced Supply Chain
George Donato - Vice President, Global Supply Operations Iroko Pharmaceuticals
This interactive format has been designed to help you problem solve with your peers in an all new format, for manufacturers only. Each boardroom topic will be hosted by an industry moderator. Sign up on the day, participation is limited to 12 people for each boardroom session. Don’t miss out on this opportunity to connect with peers and share ideas and solutions offline.

•Proactive approaches to manage supply
•Understanding which components are ripe for outsourcing
•Supply chain risk mitigation

img

George Donato

Vice President, Global Supply Operations
Iroko Pharmaceuticals

Biotech and Small to Mid-Size Manufacturer Congress Part 2

1:25 pm - 2:35 pm Supplier Relationship Management, Mitigating Risks and Partnering for Success
Joseph Berry - Director, Supply Chain Operations Amicus Therapeutics Jason Cameron - Vice President, Global Supply Chain Amicus Therapeutics
With largely outsourced supply chains, many smaller biopharma companies rely heavily on CMOs, but how do you partner with them effectively? While supplier relationship management seems like motherhood and apple pie, it takes a unique skillset to get it right, especially if you lack a procurement background. 
Find out how to:
•Set up your group to manage a diverse set of established external partners
•Effectively manage CMOs when transitioning from clinical to commercial with sound forecasts
•Ensure continuity of supply, particularly when changing suppliers
•De-risk the supply base, including shifting through phase 3 to launch

img

Joseph Berry

Director, Supply Chain Operations
Amicus Therapeutics

img

Jason Cameron

Vice President, Global Supply Chain
Amicus Therapeutics

2:35 pm - 2:55 pm Supplier Relationship Management in the Industry 4.0 Environment

Luiz Barberini - Operations Manager - External Manufacturing Latin America Head Bayer
We’re in the midst of the fourth industrial revolution. As the industry looks to get more out of automation, IoT, big data and beyond, what will best practices look like in an industry so heavily reliant on third parties for manufacturing and logistics? Luiz Barberini, Operations Manager External Manufacturing, Latin America for Bayer is re-thinking how to get the best outcome from their relationships considering a new production reality and new capabilities coupled with sound relationship management to be more competitive. To get this, Bayer needed to review their strategy.
Find out what you need to know to optimize the supply chain in Industry 4.0 including:
•The complex needs of compliant reliable supply, all the time, every time.
•How to manage different aspects of the relationship process and guarantee the best service.
•Governance that works to manage relationships
•Top tips on current supplier management

img

Luiz Barberini

Operations Manager - External Manufacturing Latin America Head
Bayer

2:55 pm - 3:35 pm 7th Inning Stretch in the LogiLounge

Stretch your legs and enjoy ballpark style treats while exploring The LogiLounge. 

3:35 pm - 3:55 pm Case Study | Establishing an External Supplier Operations (ESO) Supply Chain Organization across Divisions to Increase Efficiency and Optimize Performance

Jounal Shaikh - Head of Supply Chain Management, Americas External Supply Operations Novartis
Novartis recently underwent a major transformation to create a new harmonized technical operations organization to serve Novartis, Sandoz and Alcon under one model.  Jounal Shaikh, Head of Supply Chain Management, External Supply Operations is leading this effort for the Americas, implementing and adapting the model to improve the overall performance of the Supply Chain.  Jounal will shed light lessons learned in establishing new operational excellence standards internally and externally to better manage suppliers and how his team is collaborating across divisions making everything systematic to increase visibility in preparation for going digital.
Hear lessons learned including:
•One Supply Chain Organization – Multiple Business Models 
•Executing on the Supplier Relationship Team Approach to Supplier Management
•Implementing a Cross Divisional Integrated Business Planning Cycle 
•Determining the right performance metrics and supplier segmentation for a complex business model
•Rolling out operational excellence standards to suppliers and overcoming pain points

img

Jounal Shaikh

Head of Supply Chain Management, Americas External Supply Operations
Novartis

Since the day was jam-packed with detailed presentations and thought-provoking panel discussions, here’s your opportunity to be part of the discussion! You pick which roundtables to partake in – choose the ones relevant to your most pressing initiatives and send your teammates to others to cover full ground. Each Roundtable discussion lasts 30 minutes – choose 2!

#1 Enhancing Supply Chain Processes for More Automation and Less Manual Intervention
Mark Holder, Executive Director, Regional Supply North America, AstraZeneca  

#2 Assessing and Mitigating Risk in the Global Supply Chain
Dave Palew, Director, Supply Chain, Aurobindo

#3 Overcoming the Challenges of Truck Shortages and Rising Freight Costs
Ed Ram, Senior Director, Supply Chain, Sagent Pharmaceuticals

#4 Handling Reverse Logistics on Serialized Product

img

Mark Holder

Executive Director, Regional Supply North America
AstraZeneca

img

Dave Palew

Director, Supply Chain
Aurobindo

img

Ed Ram

Senior Supply Chain Director
Sagent Pharmaceuticals

5:00 pm - 5:15 pm Closing Future Outlook | Examining Our Maturity and Next Steps to Optimize the Supply Chain, Takeaways to Share Back at the Office

After two action packed days of sessions and networking, brains will likely be swelling with new insights and ideas. We hope to take some of the work off your plates by providing takeaways to share with your colleagues. Throughout the event we will conduct live polling and Q&A to better understand our maturity as an industry and to help you better benchmark against your peers.
This discussion will collate polling results to provide clarity around:
•Maturity of digital supply chains
•Technology priorities
•Strides in innovation
•Opportunities for increased efficiency and cost reduction

5:15 pm - 5:15 pm End Of LogiPharma 2018 – See you next year!